Annals of hepatology (1117 documentos)


421.-
422.-
423.-
424.-
425.-
Association of GST null genotypes with anti-tuberculosis drug induced hepatotoxicity in Western Indian population
Gupta, Vinod H1; Singh, Meenakshi2; Amarapurkar, Deepak N3; Sasi, Preetha1; Joshi, Jyotsna M4; Baijal, Rajiv5; Kumar, Praveen H.R5; Amarapurkar, Anjali D6; Joshi, Kalpana7; Wangikar, Pramod P2
1Indian Institute of Technology Bombay, Department of Biosciences and Bioengineering, Bombay, Maharashtra. India; 2Indian Institute of Technology Bombay, Department of Chemical Engineering, Bombay, Maharashtra. India; 3Bombay Hospital and Medical Research Centre, Department of Gastroenterology and Hepatology, Bombay, Maharashtra. India; 4TN Medical College, Department of Pulmonary Medicine, Bombay, Maharashtra. India; 5Jagjivanram Western Railway Hospital, Department of Gastroenterology and Hepatology, Bombay, Maharashtra. India; 6TN Medical College, Department of Pathology, Bombay, Maharashtra. India; 7Symbiosis School of Biomedical Sciences, Department of Biotechnology, Pune, Maharashtra. India
[Annals of hepatology, México, 2013 Vol. 12 Num. 6 Nov-Dic, Pag. 959-965]

426.-
427.-
428.-
Haemophagocytic syndrome in a liver transplant patient during treatment with Telaprevir
Rodríguez Medina, Beatriz1; Blanes, Marino2; Vinaixa, Carmen1; Aguilera, Victoria1; Rubín, Angel1; Prieto, Martín1; Berenguer, Marina1
1Hospital La Fe, Unidad de Trasplante de Hígado y Hepatología, Valencia. España; 2Hospital La Fe, Unidad de Enfermedades Infecciosas, Valencia. España
[Annals of hepatology, México, 2013 Vol. 12 Num. 6 Nov-Dic, Pag. 974-978]

429.-
430.-
Hepatolithiasis with secondary cholangitis and supernumerary left hepatic lobe
Lavenant Borja, María Isabel1; Fernández Rivero, Justo2; Pachuca González, Digna3; Mercado, Miguel Angel4; Esquivel Ayanegui, Francisco5; Méndez Sánchez, Nahum2; Albores Saavedra, Jorge1; Chablé Montero, Fredy1
1Fundación Clínica Médica Sur, Departamento de Patología, México, Distrito Federal. México; 2Fundación Clínica Médica Sur, Unidad de Investigación de Hígado, México, Distrito Federal. México; 3Fundación Clínica Médica Sur, Departamento de Radiología, México, Distrito Federal. México; 4Fundación Clínica Médica Sur, Departamento de Cirugía, México, Distrito Federal. México; 5Hospital Miguel Silva, Departamento de Gastroenterología, Morelia, Michoacán. México
[Annals of hepatology, México, 2013 Vol. 12 Num. 6 Nov-Dic, Pag. 966-968]

431.-
432.-
Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis
John, B.V1; Konjeti, R2; Aggarwal, A3; López, R4; Atreja, A5; Miller, C6; Zein, N.N1; Carey, W.D1
1Cleveland Clinic, Department of Gastroenterology and Hepatology, Cleveland, Ohio. Estados Unidos de América; 2University of Connecticut, Department of Medicine, Farmington, Connecticut. Estados Unidos de América; 3Indiana University Medical Center, Department of Gastroenterology, Indianapolis, Indiana. Estados Unidos de América; 4Cleveland Clinic, Quantitative Health Sciences, Cleveland, Ohio. Estados Unidos de América; 5Mount Sinai Medical Center, Department of Gastroenterology, Nueva York. Estados Unidos de América; 6Cleveland Clinic, Cleveland, Hepato-biliary and Transplant Surgery, Cleveland, Ohio. Estados Unidos de América
[Annals of hepatology, México, 2013 Vol. 12 Num. 6 Nov-Dic, Pag. 952-958]

433.-
434.-
435.-
436.-
437.-
438.-
439.-
440.-